Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The goal of this observational study is to describe the immune signature of acute pulmonary infection.The main questions it aims to answer are:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Influenza upper respiratory infection | This cohort aims to descirbe the nasal mucosal immune response in influenza patients. We will collect nasal mucosal cells from influenza patients using Nasal Cytology Curettes. Blood samples will also be obtained from the patient. All samples will be used for single cell sequencing. |
| |
| Viral Sepsis and Viral pneumonia | The purpose of this cohort is to characterize the immune pattern of patients with viral sepsis and find specific target for the treatment of viral sepsis. Blood samples will be obtained from the viral sepsis/pneumonia patients.All samples will be used for transcriptome sequencing. |
| |
| Bacterial Sepsis and Bacterial pneumonia | This cohort served as a control for the viral sepsis/pneumonia cohort.Blood samples will be obtained from the bacterial sepsis/pneumonia patients.All samples will be used for transcriptome sequencing. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| pathogen | Other | The patients were divided into groups according to the pathogen(bacteria or virus). The influenza upper respiratory tract infection cohort will be grouped mainly according to age. |
| Measure | Description | Time Frame |
|---|---|---|
| upper respiratory infection or pneumonia or Sepsis | Patients were grouped and compared according to their diagnosis. | up to 28 days |
| Measure | Description | Time Frame |
|---|---|---|
| Clinical status | assessed by Sequential Organ Failure Assessment | days 0, 3, 7 |
| All cause mortality | up to 28 days | |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients who are diagnosed pneumonia and signed informed consent will be enrolled.
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| China-Japan Friendship Hospital | Beijing | Beijing Municipality | 100029 | China |
We will share the transcriptome data with other researchers.
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D018805 | Sepsis |
| D011024 | Pneumonia, Viral |
| D007251 | Influenza, Human |
| D012141 | Respiratory Tract Infections |
| ID | Term |
|---|---|
| D007239 | Infections |
| D018746 | Systemic Inflammatory Response Syndrome |
| D007249 | Inflammation |
| D010335 | Pathologic Processes |
Not provided
Not provided
| ID | Term |
|---|---|
| D000375 | Aging |
| ID | Term |
|---|---|
| D048788 | Growth and Development |
| D010829 | Physiological Phenomena |
Not provided
Not provided
Not provided
Not provided
Not provided
Blood was collected by the hospital nurse. Nasal mucosal cells will be obtained by Nasal Cytology Curettes.
|
| Length of hospital stay (days) |
| up to 28 days |
| Length of ICU stay (days) | up to 28 days |
| D013568 |
| Pathological Conditions, Signs and Symptoms |
| D011014 | Pneumonia |
| D014777 | Virus Diseases |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D009976 | Orthomyxoviridae Infections |
| D012327 | RNA Virus Infections |